RCA In-Ear vs Resound Vivia 9 60S microRIE

The RCA In-Ear is a budget OTC hearing aid priced at $249, earning a C grade with a SoundScore of 2.8/5 in our lab testing. This places it near the bottom of the OTC category at #64 of 65 devices tested. Speech performance is a significant weakness for this device. Speech in quiet scores just 1.0/5, falling 1.79 points below the category average, while speech in noise also scores 1.0/5, sitting 0.48 points below average. These low absolute scores indicate limited benefit for understanding conversation in most listening situations. Music streaming scored 0.0/5, measuring 1.92 points below the category average—this device is not suitable for audio entertainment. The RCA In-Ear does show strength in feedback handling, scoring an excellent 5.0/5, which is 0.46 points above the category average. Own-voice comfort is mixed at 2.6/5, essentially matching the category average with only a 0.09-point advantage. The rechargeable battery design offers convenience for daily use. At this price point, consumers have substantially higher-performing alternatives. Devices like the Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and several others in the same budget range deliver meaningfully better speech clarity and overall sound quality. The RCA In-Ear may appeal to those prioritizing feedback-free operation above all else, but most users seeking improved hearing will find better value elsewhere in the OTC market.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.